Research Articles
Chromatin Relaxation: How a Lost Epigenetic Mark Opens New Doors in Ovarian Cancer Treatment
Discover how histone H2B monoubiquitination loss in ovarian cancer creates new therapeutic opportunities based on chromatin relaxation.
Cracking the Code of Ovarian Cancer: A New Map to Stop the Tumor's Supply Lines
Discover how groundbreaking research is mapping the molecular signatures of ovarian cancer tumors to develop personalized treatments targeting their blood supply networks.
Unlocking a New Weapon in the Fight Against Ovarian Cancer
Discover how blocking both the Ubiquitin-Proteasome System and HDAC6-dependent lysosomal pathway creates synergistic killing of ovarian cancer cells.
Unlocking the Mystery of Ovarian Cancer: The USP13 Breakthrough
Discover how the USP13 gene breakthrough is revolutionizing our understanding and treatment of high-grade serous ovarian cancer.
Breaking the Shield: Targeting Cellular Waste Management for Ovarian Cancer Treatment
Exploring how targeting deubiquitinating enzymes (DUBs) associated with the proteasome could revolutionize ovarian cancer treatment by overcoming drug resistance.
Unlocking Cisplatin Resistance: How Hijacking a Cellular Switchboard Could Revolutionize Ovarian Cancer Treatment
Discover how targeting neddylation with MLN4924 could overcome cisplatin resistance in ovarian cancer, offering new hope for patients with recurrent disease.
Unlocking Nature's Arsenal: How an Ancient Malaria Drug Targets Aggressive Ovarian Cancer
Discover how dihydroartemisinin (DHA), derived from ancient antimalarial plants, targets PDGFRα in aggressive ovarian cancer, offering new hope against this lethal disease.